An expert weighs in on the factors driving a growing number of dermatologists to sell their practices.
Medical device company, Soliton will present results from their 12-week study looking at the treatment of fibrotic scars using their RAP device at Maui Derm Jan. 25-29.
Men present with melasma too, but there are differentiating factors compared with female melasma patients. Researchers offer insights from a literature review for effectively treating the male melasma patient.
Risankizumab (SKYRIZI, AbbVie), outperformed secukinumab (Cosentyx, Novartis) in a head-to-head phase 3 study comparing the two treatments in adult patients with moderate to severe plaque psoriasis, according to data released by the company Jan. 14.
What actions should a medical practice take to protect itself from a data breach? This expert weighs in.
Recent phase 3 clinical trials reveal positive results for tazarotene lotion 0.045% in patients with moderate-to-severe acne.
Off-label product use is fairly common in aesthetics and plays a key role in advancing treatment practices in the specialty. Dr. Amy Foreman Taub explains the four she uses on a regular basis.
View the highlights from our January 2020 issue in this slideshow.
Anneke Andriessen, Ph.D. discusses research that suggests controlling symptoms with moisturizers can be an important — and inexpensive — prevention and treatment tactic for pediatric patients with atopic dermatitis.
Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.